This trial was conducted to evaluate the role of the patient's own bone marrow stem cells for spinal cord injury. The trial was conducted at General Hospital of Chinese People's Armed Police Forces in Beijing and sought to whether giving the participants the stem cells via intravenous (IV) infusion was any different to delivering the cells by surgical transplantation directly at the site of the lesion. The trial sought to recruited 27 subjects with Spinal Cord Injury by February 2012. Nine of these subjects underwent an open surgical transplantation with mesenchymal stem cells from the patient's bone marrow, whilst another nine received an intravenous infusion of their mesenchymal stem cells. A final group of nine was the control group which did not receive cells. There does not appear to be any other information regarding experimental protocol, trial outcomes or results available.